Buchumschlag

Chinese Expert Consensus on the Clinical Diagnosis and Management of Statin Intolerance

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jian‐Jun Li, Ke‐Fei Dou, Zhi‐Guang Zhou, Dong Zhao, Ping Ye, Hong Chen, Zhen‐Yue Chen, Dao‐Quan Peng, Yuan‐Lin Guo, Na‐Qiong Wu, Jie Qian
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Clinical Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Letter: The Unresolved Issue of NSBB Confounding in Statin Research for Cirrhosis
von: Deliang Huang, et al.
Veröffentlicht: (2026)

Risk of Opioid Overdose Associated with Concomitant Use of Methadone and Statins
von: Cheng Chen, et al.
Veröffentlicht: (2024)

Letter: The Essential Role of Social Workers in Reducing Socioeconomic Disparities in Chronic Liver Disease
von: Qiong Yi, et al.
Veröffentlicht: (2024)

Letter: Statins for Cirrhosis: Are We Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management?
von: Abdulrahman Ismaiel
Veröffentlicht: (2026)

Letter: Statins for Cirrhosis: Are we Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management? Authors' Reply
von: Bernardo de Faria Moraes, et al.
Veröffentlicht: (2026)

Editorial: Statin Therapy in Cirrhosis: More Than Just Lipid‐Lowering
von: Emily Stephenson, et al.
Veröffentlicht: (2026)

Letter: Late Diagnosis of Chronic Hepatitis B—Quantifying the Missed Opportunities and Clinical Consequences
von: Bi‐Yu Gao, et al.
Veröffentlicht: (2025)

Development and Validation of the Pharmacological Statin‐Associated Muscle Symptoms Risk Stratification Score Using Electronic Health Record Data
von: Boguang Sun, et al.
Veröffentlicht: (2024)

Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease
von: Uma Mahadevan, et al.
Veröffentlicht: (2025)

Statin Therapy Independently Reduces Mortality and Liver Complications in Patients With Cirrhosis: An Updated Systematic Review and Meta‐Analysis
von: Bernardo de Faria Moraes, et al.
Veröffentlicht: (2026)

Uncovering Coenzyme Q10 ‐Related Genetic Determinants of Statin‐Associated Muscle Symptoms: Evidence from the UK Biobank and the All of Us Research Program
von: Da Hoon Lee, et al.
Veröffentlicht: (2026)

Biopsy‐Sparing Diagnosis of Coeliac Disease Based on Endomysial Antibody Testing and Clinical Risk Assessment
von: Stiliano Maimaris, et al.
Veröffentlicht: (2025)

SLCO1B1 Functional Variants, Bilirubin, Statin‐Induced Myotoxicity, and Recent Sub‐Saharan African Ancestry: A Precision Medicine Health Equity Study
von: Tanushree Haldar, et al.
Veröffentlicht: (2025)

Editorial: Accelerometers to Quantify Physical Activity in MASLD—Impact on Clinical Outcomes
von: Vincent L. Chen
Veröffentlicht: (2025)

Revisiting Tirzepatide’s Body Composition Model: Underestimated Fat‐Free Mass Loss and Clinical Implications
von: Chun‐Chieh Chen, et al.
Veröffentlicht: (2025)

Dietary factors and patterns in relation to risk of later‐onset ulcerative colitis in Chinese: A prospective study of 0.5 million people
von: Shuyao Song, et al.
Veröffentlicht: (2024)

Virological and Immunological Characteristics of HBeAg ‐Positive Chronic Hepatitis B Patients With Low HBsAg Levels
von: Yuxin Chen, et al.
Veröffentlicht: (2024)

Letter: Double PBC ‐Related Autoantibody Positivity—How Essential Is It for Diagnosis? Authors' Reply
von: Hong‐Li Liu, et al.
Veröffentlicht: (2026)

Clinical Trial: Effect of Abdominal Vibration Combined With Walking Exercise Programme on Bowel Preparation in Older Patients With Constipation
von: Yuan‐Yuan Zhang, et al.
Veröffentlicht: (2025)

Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence‐Based Review on Emerging Clinical Data
von: Yujing Li, et al.
Veröffentlicht: (2024)

Editorial: Diabetes Management in Cirrhosis—The Window of Opportunity Before Decompensation. Authors' Reply
von: Mary Yue Wang, et al.
Veröffentlicht: (2026)

Liver Fibrosis and the Risk of Coronary Artery Disease, Stent Thrombosis, Restenosis and Adverse Clinical Outcomes
von: Na Tian, et al.
Veröffentlicht: (2025)

Editorial: Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection—Authors' Reply
von: Yu‐Ping Chang, et al.
Veröffentlicht: (2025)

Review article: Diagnosis and management of laryngopharyngeal reflux
von: Amanda J. Krause, et al.
Veröffentlicht: (2024)

Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Studies Related to Vincristine‐Induced Peripheral Neuropathy in Chinese Pediatric ALL Patients
von: Yawen Yuan, et al.
Veröffentlicht: (2024)

A Comparative Clinical Pharmacology Analysis of FDA‐Approved Targeted Covalent Inhibitors vs. Reversible Inhibitors in Oncology
von: Huy X. Ngo, et al.
Veröffentlicht: (2024)

Letter: From Regional Diagnostic Thresholds to Phenotype‐Guided Management in Asian Reflux Disease. Authors' Reply
von: Walter W. Chan, et al.
Veröffentlicht: (2026)

Editorial: Revolutionising Steatotic Liver Disease Diagnosis With Phosphatidylethanol
von: Karen Cheuk‐Ying Ho, et al.
Veröffentlicht: (2025)

Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins
von: Yow‐Ming C. Wang, et al.
Veröffentlicht: (2024)

Letter: Comparison of the Efficacy of Adjuvant PD‐1 Inhibitor After Curative Resection for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Related HCC Versus Other Aetiologies
von: Jia‐Yong Su, et al.
Veröffentlicht: (2025)

Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
von: Prathap Nagaraja Shastri, et al.
Veröffentlicht: (2024)

M et ALD : Diagnosis and Prognosis With Non‐Invasive Tests
von: Nikolaj Torp, et al.
Veröffentlicht: (2025)

Effects of GLPG3970 on Sulfasalazine and Methotrexate Pharmacokinetics in Healthy Adults: Two Open‐Label, Phase I, Drug–Drug Interaction Studies
von: Mariska van der Plas, et al.
Veröffentlicht: (2024)

Editorial: HBeAg ‐Positive Chronic Hepatitis B With Low HBsAg Levels—Exploring Clinical Significance of preS2 Deletion Mutations. Authors' Reply
von: Yuxin Chen, et al.
Veröffentlicht: (2025)

Ongoing Pharmacological Developments in SLC6A1 Research & Treatment
von: Melissa B. DeLeeuw, et al.
Veröffentlicht: (2024)

Volatomics for Diagnosis and Risk Stratification of MASLD: A Proof‐Of‐Concept Study
von: R. Sinha, et al.
Veröffentlicht: (2025)

Editorial: Revolutionising Steatotic Liver Disease Diagnosis With Phosphatidylethanol—Authors' Reply
von: Federica Tavaglione, et al.
Veröffentlicht: (2025)

Editorial: HDV Diagnosis Implementation: Gains in Systematic Screening, Gaps in Standardisation
von: Sara Battistella, et al.
Veröffentlicht: (2026)

Diagnosis and non‐invasive assessment of MASLD in type 2 diabetes and obesity
von: Wah‐Kheong Chan, et al.
Veröffentlicht: (2024)

Letter: Double PBC ‐Related Autoantibody Positivity—How Essential Is It for Diagnosis?
von: Alessandro Granito, et al.
Veröffentlicht: (2026)